Right Ventricular Dysfunction
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Edwards LifesciencesCA - Irvine
1 programPaceport Swan-Ganz Data Collection StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Colorado TherapeuticsFerrous sulfate 325mg
Edwards LifesciencesPaceport Swan-Ganz Data Collection Study
Clinical Trials (2)
Total enrollment: 141 patients across 2 trials
Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
Start: Mar 2028Est. completion: May 20305 patients
Phase 1Not Yet Recruiting
Paceport Swan-Ganz Data Collection Study
Start: Aug 2021Est. completion: Apr 2022136 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.